How will newly approved antiviral treatment affect the Omicron wave?
Credit: CBC News
Deputy chief public health officer Dr. Howard Njoo and Health Canada’s chief medical adviser, Dr. Supriya Sharma, lay out how significantly Pfizer’s new antiviral drug, Paxlovid, will affect Canadians in the midst of the Omicron wave.
For more than 75 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio, CBCNews.ca, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians.


This article comes from NationTalk:
https://nationtalk.ca
The permalink for this story is:
https://nationtalk.ca/story/how-will-newly-approved-antiviral-treatment-affect-the-omicron-wave
Comments are closed.